Radioisotope manufacturer NorthStar Medical Technologies names new CEO

NorthStar Medical Technologies, a Wisconsin-based manufacturer of radiopharmaceuticals and radioisotopes, has named a new CEO.

The manufacturer named former COO Frank Scholz as CEO, replacing Steven Merrick who has been in the top spot since 2018. Merrick will still be involved with the company as executive chairman, and Scholz will assume the CEO duties starting on June 26.

In an interview with Endpoints News, Scholz said that his overarching goal is to help patients, particularly those with cancer. Scholz takes over as the company is expanding its offerings and its physical space.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

Advancing hepatic cell carcinoma treatment through mitochondrial DNA targeting

Hepatic cell carcinoma (HCC), the fifth most prevalent malignancy worldwide and the fourth leading cause of cancer-related mortality, poses significant therapeutic challenges.

July 29, 2024

Rising complaints of unauthorized Obamacare plan-switching and sign-ups trigger concern

Federal and state regulators aren’t doing enough to stop the growing problem of rogue health insurance brokers making unauthorized policy switches for Affordable Care Act

April 8, 2024

Which Vaccines Should You Get and Recommend This Fall?

In this video interview, Paul Offit, MD, of Children’s Hospital of Philadelphia and a member of FDA’s Vaccines and Related Biological Products Advisory Committee, gives

September 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.